Serum Institute asked to revise protocol to conduct Oxford's coronavirus vaccine Phase 2, 3 human trials

Serum Institute of India (SII), who earlier sought permission to conduct Phase-2 and 3 trials of Oxford University's coronavirus vaccine in India, has been advised to resubmit a revised protocol to carry out trials for the potential coronavirus vaccine. The Central Drugs Standard Control Organisation (CDSCO) has asked SII to submit a revised protocol after its Subject Expert Committee evaluated the earlier protocol submitted by it.

from IndiaTV India: Google News Feed https://ift.tt/3ggD1Ng